Theory Financial’s AbbVie ABBV Stock Holding History

Theory Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Hold	944	–	–	0.07%	94
2025 Q4	$208K	Hold	944	–	–	0.07%	100
2025 Q3	$219K	Buy	+944	New	+$192K	0.08%	86
2025 Q2	–	Sell	-983	Closed	-$206K	–	85
2025 Q1	$206K	Buy	+983	New	+$191K	0.09%	79
2024 Q1	–	Sell	-3,923	Closed	-$608K	–	75
2023 Q4	$608K	Sell	3,923 -373	-9%	-$54.4K	0.32%	43
2023 Q3	$640K	Buy	4,296 +60	+1%	+$8.81K	0.38%	43
2023 Q2	$571K	Hold	4,236	–	–	0.33%	44
2023 Q1	$675K	Hold	4,236	–	–	0.41%	42
2022 Q4	$685K	Buy	+4,236	New	+$650K	0.45%	40
2022 Q2	$670K	Buy	4,350 +72	+2%	+$11K	0.48%	42
2022 Q1	$694K	Hold	4,278	–	–	0.46%	38
2021 Q4	$579K	Buy	+4,278	New	+$505K	0.38%	33

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Theory Financial's ABBV Position: Q1 2026 in Review

Theory Financial held its AbbVie (ABBV) position steady in Q1 2026 at 944 shares worth $205K. The position accounts for 0.07% of the portfolio, ranked #94.

Theory Financial first reported a position in ABBV in Q4 2021 and has held it in 12 quarters since. The position peaked at $694K in Q1 2022. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Theory Financial held 944 shares of AbbVie worth $205K as of Q1 2026.
Theory Financial left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.07% of Theory Financial's portfolio in Q1 2026, its #94 holding.
Theory Financial first reported a position in AbbVie in Q4 2021 and has held it in 12 quarters since.
Theory Financial's AbbVie position peaked at $694K in Q1 2022.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Theory Financial's 13F filing for Q1 2026, filed 5 May 2026.